Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Global News Feed
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
Posted: April 23, 2023 at 12:20 am
The application refers to a novel psychedelic-based combination of Clearmind's MEAI and SciSparc's Cannamide™
Read this article:
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
Posted in Global News Feed
Comments Off on SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
Posted: April 23, 2023 at 12:20 am
The application is for a novel psychedelic-based combination, of Clearmind's MEAI and SciSparc's Cannamide™
More here:
Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
Posted in Global News Feed
Comments Off on Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
LianBio Promotes Pascal Qian to Chief Commercial Officer
Posted: April 23, 2023 at 12:20 am
SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the promotion of Pascal Qian to the position of Chief Commercial Officer. He will continue to also serve as the company’s China General Manager.
Read more from the original source:
LianBio Promotes Pascal Qian to Chief Commercial Officer
Posted in Global News Feed
Comments Off on LianBio Promotes Pascal Qian to Chief Commercial Officer
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
Posted: April 23, 2023 at 12:20 am
WATERTOWN, Mass., April 21, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., Chief Executive Officer and President of Disc Medicine, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday, May 2, 2023 at 2:30 p.m. ET.
More here:
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
Posted in Global News Feed
Comments Off on Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The…
Posted: April 23, 2023 at 12:20 am
Data accepted as AAN Late-Breaking Abstract Data accepted as AAN Late-Breaking Abstract
Posted in Global News Feed
Comments Off on Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The…
Ultimovacs ASA – Share Option Program
Posted: April 23, 2023 at 12:20 am
Oslo, 21 April 2023: On the basis of the approval by the General Meeting on 20 April 2023 to authorize the Board of Directors of Ultimovacs ASA (the ‘Company’, OSE ticker “ULTI”) to issue new shares to employees under a long-term incentive program, the Board of Directors has resolved to issue share options to employees in the Company.
Read the original:
Ultimovacs ASA - Share Option Program
Posted in Global News Feed
Comments Off on Ultimovacs ASA – Share Option Program
Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
Posted: April 23, 2023 at 12:20 am
Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer T (“NKT”) modulating therapies for the treatment of inflammatory, fibrotic and autoimmune diseasesInvestment proceeds expected to fund planned operations of the combined company into mid-2024
Read the original here:
Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
Posted in Global News Feed
Comments Off on Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
Tenaya Therapeutics to Participate at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Posted: April 23, 2023 at 12:20 am
SOUTH SAN FRANCISCO, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit. Details of participation are as follows:
Originally posted here:
Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Posted in Global News Feed
Comments Off on Tenaya Therapeutics to Participate at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Arvinas to Present at Stifel Targeted Oncology Day
Posted: April 23, 2023 at 12:20 am
NEW HAVEN, Conn., April 21, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ian Taylor, Ph.D., Chief Scientific Officer, and Sean Cassidy, Chief Financial Officer, will participate in a fireside at the Stifel Targeted Oncology Day on Wednesday, April 26 at 11:30 a.m. ET.
See the article here:
Arvinas to Present at Stifel Targeted Oncology Day
Posted in Global News Feed
Comments Off on Arvinas to Present at Stifel Targeted Oncology Day
AB Science announces the implementation of a new strategy and the launch of a capital increase
Posted: April 23, 2023 at 12:20 am
PRESS RELEASE
Read more from the original source:
AB Science announces the implementation of a new strategy and the launch of a capital increase
Posted in Global News Feed
Comments Off on AB Science announces the implementation of a new strategy and the launch of a capital increase